Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol vs Dexamethasone for Impending Recurrent Pterygium
NCT04075227Phase 4Completed
- Start
- Oct 2015
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of loteprednol etabonate ophthalmic gel 0.38% in pterygium. Started Oct 2015; status: completed.
02
Drugs
loteprednol etabonate ophthalmic gel 0.38%
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT04075227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04075227.